A 12 week, double -blind, parallel study of atrovent inhaler conducted in asthmatic patients who are on concurrent bronchodilator therapy. The study evaluates the long term safety and efficacy of atrovent inhaler compared to placebo.
Showing the most recent 10 out of 465 publications